Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Episodic Migraine: later-stage trial registry
7 of 14 indexed Episodic Migraine trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 7 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Episodic Migraine: 14 US clinical trials tracked, 7 recruiting.
Episodic Migraine is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Click Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition episodic-migraine
OPEN 7 | RECR 50% | LATE 9 | EARLY 2 | RANK #1230 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Episodic Migraine lists 7 open slots (50% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Episodic Migraine on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Episodic Migraine is recruiting above its size-band peers.
7 of 14 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Episodic Migraine trials is spread across many organizations.
Click Therapeutics accounts for 2 of 14 trials (14.3%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Episodic Migraine enrolment sits around 568 participants.
Median target enrolment is 568 among the 14 trials that report a genuine target (sentinel values excluded). 3 of those (21.4%) plan for fewer than 100 participants.
-
Episodic Migraine research is mostly interventional.
13 interventional and 1 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Merz Therapeutics
NCT07018700
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Hospital Universitari Vall d'Hebron Research Institute
NCT07159750
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Ipsen
NCT06625060
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
AbbVie
NCT05711394
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
H. Lundbeck A/S
NCT05897320
Chiropractic Care for Episodic Migraine
Brigham and Women's Hospital
NCT06229834
Efficacy of Nerve Blocks for Episodic Migraine
Mayo Clinic
NCT05734625
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Ipsen
NCT06047457
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Eli Lilly and Company
NCT03432286
Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients
Amgen
NCT03927144
A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine
Eli Lilly and Company
NCT05127486
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
Click Therapeutics
NCT05853900
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)
Click Therapeutics
NCT06004388
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
Beth Israel Deaconess Medical Center
NCT00719134
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 6 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Episodic Migraine records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Episodic Migraine trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Episodic Migraine page
14 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Episodic Migraine trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Click Therapeutics sponsors the most Episodic Migraine trials on record, review their full trial history before evaluating a specific study. See Click Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Episodic Migraine condition card totals 14 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.